CorCell: Umbilical Cord Blood Banking
expectant families insurance programs existing customers healthcare providers getting started about corcell
Strategic Alliances
AirNet Alex's Lemonade Stand Insurance Partners Medline National Labor Office of the Blue Cross Blue Shield Association Women's Health Care Group of PA

Sign Up for a CorCell Information Packet

Order a CorCell Gift Certificate

Progenitor Cell Therapy

CorCell has a strategic partnership with Progenitor Cell Therapy (PCT) for the processing and storage of cord blood stem cell specimens, offering our customers a unique advantage for access to future therapies.

Based in Hackensack, New Jersey, Progenitor Cell Therapy is an industry leader in developing and manufacturing cell therapies, ensuring that our customers have access to a potent therapy if and when it is needed for applications beyond basic transplantation. The lab processes and stores your baby's cord blood to standards that exceed FDA cord blood requirements using Good Manufacturing Practice standards (cGMP). This means your baby's cord blood will not only be viable for current therapies, but will meet the standards of future therapies that are currently being researched and developed today.

Progenitor Cell Therapy has a long term commitment to the development of effective cell therapies as the emerging paradigm for the treatment of disease. Their unique and wide-ranging experience spans the entire spectrum of cell therapy product development from research to processing and manufacturing, and from regulatory and quality compliance to clinical application.

Progenitor Cell Therapy was one of the first labs to expand a cord blood specimen that was successfully transplanted. The patient was diagnosed with High Risk Chronic Myelogenous Leukemia and is doing very well 7 years post transplant.

Progenitor Cell Therapy's management team has over 100 years combined experience in cell therapy, built 5 cGMP facilities, and participated in over 50 regulatory filings in the US and Europe. The company has served over 100 clients, worked with over 20 different types of cells, and has generated over 17,000 cell therapy products of which approximately 5,000 have already been used for patient treatment.

Following are licenses and accreditations maintained by Progenitor Cell Therapy.

  • Registered with the FDA to serve as a cord blood bank
  • Operating under cGMP standards
  • Licensed in the states of NY, NJ, CA and MD
  • Clinical Laboratory Improvement Amendments - Federal certification by the Health Care Financing Administration.
  • American Society of Histocompatability and Immunogenetics
  • FACT accredited cellular therapy facility

To learn more about Progenitor Cell Therapy and their distinction as an industry leader, visit their website at www.progenitorcelltherapy.com.